Ma Jun, Zhao Nan, Betts Lexxus, Zhu Donghui
Department of Chemical, Biological and Bioengineering, North Carolina Agricultural and Technical State University, Greensboro, NC, USA; NSF Engineering Research Center-Revolutionizing Metallic Biomaterials, North Carolina Agricultural and Technical State University, Greensboro, NC, USA.
J Mater Sci Technol. 2016 Sep;32(9):815-826. doi: 10.1016/j.jmst.2015.12.018. Epub 2015 Dec 24.
Biodegradable magnesium (Mg) alloy stents are the most promising next generation of bio-absorbable stents. In this article, we summarized the progresses on the studies, animal testing and clinical trials of biodegradable Mg alloy stents in the past decades. These exciting findings led us to propose the importance of the concept "bio-adaption" between the Mg alloy stent and the local tissue microenvironment after implantation. The healing responses of stented blood vessel can be generally described in three overlapping phases: inflammation, granulation and remodeling. The ideal bio-adaption of the Mg alloy stent, once implanted into the blood vessel, needs to be a reasonable function of the time and the space/dimension. First, a very slow degeneration of mechanical support is expected in the initial four months in order to provide sufficient mechanical support to the injured vessels. Although it is still arguable whether full mechanical support in stented lesions is mandatory during the first four months after implantation, it would certainly be a safety design parameter and a benchmark for regulatory evaluations based on the fact that there is insufficient human data available, especially the vessel wall mechanical properties during the healing/remodeling phase. Second, once the Mg alloy stent being degraded, the void space will be filled by the regenerated blood vessel tissues. The degradation of the Mg alloy stent should be 100% completed with no residues, and the degradation products (e.g., ions and hydrogen) will be helpful for the tissue reconstruction of the blood vessel. Toward this target, some future research perspectives are also discussed.
可生物降解镁(Mg)合金支架是最具前景的下一代生物可吸收支架。在本文中,我们总结了过去几十年可生物降解镁合金支架在研究、动物试验和临床试验方面取得的进展。这些令人振奋的发现使我们提出了植入后镁合金支架与局部组织微环境之间“生物适应性”这一概念的重要性。置入支架血管的愈合反应通常可分为三个相互重叠的阶段:炎症、肉芽组织形成和重塑。镁合金支架一旦植入血管,理想的生物适应性需要在时间和空间/维度上合理发挥作用。首先,在最初的四个月里,预计机械支撑会非常缓慢地退化,以便为受损血管提供足够的机械支撑。尽管在植入后的头四个月内,支架病变处是否需要完全的机械支撑仍存在争议,但基于目前缺乏足够的人体数据,尤其是愈合/重塑阶段血管壁的力学性能,这肯定是一个安全设计参数和监管评估的基准。其次,一旦镁合金支架降解,空隙将被再生的血管组织填充。镁合金支架的降解应100%完成且无残留,降解产物(如离子和氢气)将有助于血管的组织重建。针对这一目标,我们还讨论了一些未来的研究方向。